Total Payments
$12,688
2024 Payments
$2,260
Companies
56
Transactions
748
Medicare Patients
4,601
Medicare Billing
$363,400
Payment Breakdown by Category
Food & Beverage$12,228 (96.4%)
Education$460.63 (3.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,228 | 742 | 96.4% |
| Education | $460.63 | 6 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,401 | 87 | $0 (2024) |
| Lilly USA, LLC | $1,390 | 82 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,032 | 63 | $0 (2024) |
| Amgen Inc. | $986.81 | 63 | $0 (2024) |
| ABBVIE INC. | $862.45 | 60 | $0 (2024) |
| Astellas Pharma US Inc | $843.77 | 31 | $0 (2024) |
| PFIZER INC. | $701.59 | 39 | $0 (2024) |
| GlaxoSmithKline, LLC. | $549.48 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $464.91 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $460.96 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,260 | 115 | Lilly USA, LLC ($379.74) |
| 2023 | $2,170 | 119 | Lilly USA, LLC ($297.32) |
| 2022 | $1,957 | 117 | Lilly USA, LLC ($259.86) |
| 2021 | $1,570 | 94 | Amgen Inc. ($234.40) |
| 2020 | $1,268 | 79 | Allergan, Inc. ($185.28) |
| 2019 | $1,141 | 81 | Lilly USA, LLC ($167.31) |
| 2018 | $1,090 | 68 | Novo Nordisk Inc ($203.61) |
| 2017 | $1,232 | 75 | Novo Nordisk Inc ($235.37) |
All Payment Transactions
748 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: VACCINES | ||||||
| 12/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Obesity | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: UROLOGY | ||||||
| 11/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: UROLOGY | ||||||
| 11/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: VACCINE | ||||||
| 11/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: PAIN | ||||||
| 11/06/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Neurology | ||||||
| 10/31/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.78 | General |
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.31 | General |
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Neurology | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.81 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,566 | 1,805 | $342,544 | $115,767 |
| 2022 | 1 | 17 | 36 | $1,833 | $968.41 |
| 2021 | 9 | 987 | 1,213 | $207,008 | $79,960 |
| 2020 | 13 | 2,031 | 2,928 | $454,398 | $166,704 |
Total Patients
4,601
Total Services
5,982
Medicare Billing
$363,400
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 406 | 553 | $152,075 | $34,685 | 22.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 202 | 202 | $55,550 | $29,250 | 52.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 192 | 267 | $57,939 | $14,921 | 25.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 154 | 154 | $20,790 | $11,675 | 56.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $7,700 | $6,224 | 80.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 21 | 21 | $12,705 | $5,229 | 41.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 135 | 135 | $5,400 | $4,675 | 86.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 245 | 261 | $18,230 | $3,220 | 17.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 19 | 19 | $5,035 | $2,485 | 49.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 77 | 77 | $3,080 | $1,389 | 45.1% |
| 90471 | Administration of vaccine | Office | 2023 | 56 | 57 | $2,280 | $987.92 | 43.3% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 15 | 15 | $825.00 | $474.05 | 57.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $440.00 | $380.93 | 86.6% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 11 | 11 | $495.00 | $171.60 | 34.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 17 | 36 | $1,833 | $968.41 | 52.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 282 | 352 | $88,075 | $31,186 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 139 | 139 | $38,225 | $21,302 | 55.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 202 | 257 | $55,769 | $15,988 | 28.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 22 | 117 | $5,643 | $3,489 | 61.8% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 72 | 72 | $2,894 | $2,894 | 100.0% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 55 | 55 | $2,207 | $2,207 | 100.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 164 | 170 | $11,900 | $2,032 | 17.1% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2021 | 28 | 28 | $1,260 | $445.76 | 35.4% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 23 | 23 | $1,035 | $415.15 | 40.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 319 | 569 | $142,250 | $50,746 | 35.7% |
About Sean Saedi, M. D
Sean Saedi, M. D is a Internal Medicine healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003896234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sean Saedi, M. D has received a total of $12,688 in payments from pharmaceutical and medical device companies, with $2,260 received in 2024. These payments were reported across 748 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($12,228).
As a Medicare-enrolled provider, Saedi has provided services to 4,601 Medicare beneficiaries, totaling 5,982 services with total Medicare billing of $363,400. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Silver Spring, MD
- Active Since 01/23/2006
- Last Updated 03/07/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003896234
Products in Payments
- Ozempic (Drug) $594.10
- MOUNJARO (Drug) $483.68
- JARDIANCE (Drug) $470.83
- Aimovig (Biological) $456.30
- XARELTO (Drug) $419.11
- VRAYLAR (Drug) $417.92
- EMGALITY (Drug) $361.11
- FARXIGA (Drug) $347.92
- NURTEC ODT (Drug) $327.54
- Vascepa (Drug) $324.30
- TRELEGY ELLIPTA (Drug) $318.71
- Kerendia (Drug) $307.64
- TRULICITY (Drug) $302.94
- QULIPTA (Drug) $296.14
- UBRELVY (Drug) $282.42
- ENTRESTO (Drug) $273.62
- ELIQUIS (Drug) $256.65
- MYRBETRIQ (Drug) $236.09
- JANUVIA (Drug) $228.02
- Otezla (Drug) $208.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Silver Spring
Dr. Kashif Ali, M.d, M.D
Internal Medicine — Payments: $930,688
Internal Medicine $930,688
Dr. Jose Bonelli, M.d, M.D
Internal Medicine — Payments: $46,617
Internal Medicine $46,617
Dr. Pirooz Mofrad, Md, MD
Internal Medicine — Payments: $44,528
Internal Medicine $44,528
Dr. Luis Gonzalez, M.d, M.D
Internal Medicine — Payments: $22,563
Internal Medicine $22,563
Maria Menucci, M.d, M.D
Internal Medicine — Payments: $19,792
Internal Medicine $19,792
Dr. Rajeev Batra, M.d, M.D
Internal Medicine — Payments: $6,905
Internal Medicine $6,905